Background Despite being one of the commonest causes of cancer-related death around
the world, only 20 per cent of hepatocellular carcinomas (HCCs) are amenable to curative …

Hepatocellular carcinoma (HCC) is an increasingly common disease with dismal long-term
survival. Percutaneous ablation has gained popularity as a minimally invasive, potentially …

Aim: We surveyed multiple centers to identify types and frequency of complications and
mortality rate associated with radiofrequency ablation (RFA) of hepatocellular carcinoma …

Purpose To prospectively determine optimal parameters with which to achieve defined large
target zones of coagulation by using irreversible electroporation (IRE) with four-electrode …

Hepatocellular carcinoma (HCC) is the second commonest cancer in Taiwan. The national
surveillance program can detect HCC in its early stages, and various curative modalities …

Purpose To evaluate technique effectiveness, safety, and interoperator performance of
stereotactic radiofrequency ablation (SRFA) of liver lesions. Methods Retrospective review …

Purpose To prospectively assess the safety and mid-term therapeutic effectiveness of
monopolar radiofrequency (RF) ablation with a multiple-electrode switching system for …

Aim To evaluate the incidence of adverse events and associated factors after radiofrequency
ablation (RFA) in patients with hepatocellular carcinoma within 30 days. Materials and …

BACKGROUND A wide range of ablative and non-surgical therapies are available for
treating small hepatocellular carcinoma in patients with very early or early-stage disease …

Advances in diagnostic imaging and fine-needle biopsy technique have permitted the
development of percutaneous ablation therapies (PATs). These therapies are performed …